SPALLONE, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.172
AS - Asia 861
EU - Europa 639
SA - Sud America 128
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.826
Nazione #
US - Stati Uniti d'America 4.141
SG - Singapore 397
CN - Cina 193
RU - Federazione Russa 132
BR - Brasile 102
IT - Italia 88
VN - Vietnam 87
DE - Germania 86
IE - Irlanda 86
HK - Hong Kong 85
UA - Ucraina 56
FR - Francia 44
GB - Regno Unito 40
SE - Svezia 37
FI - Finlandia 29
CA - Canada 15
JP - Giappone 15
IN - India 13
BD - Bangladesh 11
KR - Corea 11
TR - Turchia 9
MX - Messico 8
EG - Egitto 7
ID - Indonesia 7
ZA - Sudafrica 7
PL - Polonia 6
AT - Austria 5
EC - Ecuador 5
IQ - Iraq 5
PE - Perù 5
AR - Argentina 4
DK - Danimarca 4
ES - Italia 4
NL - Olanda 4
BE - Belgio 3
CL - Cile 3
KG - Kirghizistan 3
LT - Lituania 3
PK - Pakistan 3
RO - Romania 3
UY - Uruguay 3
VE - Venezuela 3
DZ - Algeria 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
MA - Marocco 2
MY - Malesia 2
PY - Paraguay 2
TH - Thailandia 2
UZ - Uzbekistan 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
Totale 5.826
Città #
Houston 761
Wilmington 702
Woodbridge 619
Fairfield 265
Singapore 242
Chandler 227
Ashburn 195
Seattle 125
Ann Arbor 121
Cambridge 103
San Jose 96
New York 86
Dublin 85
Hong Kong 85
Beijing 82
Medford 63
Dearborn 57
Santa Clara 40
Jacksonville 39
Ho Chi Minh City 33
Los Angeles 31
The Dalles 30
Council Bluffs 29
Lawrence 29
Moscow 22
Munich 22
Lauterbourg 20
Rome 19
Buffalo 18
Helsinki 18
Hanoi 17
San Diego 14
Tokyo 14
Dallas 13
São Paulo 12
Boardman 11
Chicago 10
Nuremberg 10
Redwood City 10
Montreal 9
Orem 8
Shanghai 8
Turin 8
Zhengzhou 8
Ankara 7
Brooklyn 7
Chennai 7
Denver 7
Florence 7
London 7
Menlo Park 7
Norwalk 7
Poplar 7
Alexandria 6
Johannesburg 6
San Francisco 6
Da Nang 5
Falls Church 5
Guangzhou 5
Hefei 5
Jakarta 5
Lima 5
Milan 5
Mülheim 5
Stockholm 5
Belo Horizonte 4
Guarulhos 4
Haiphong 4
Jinan 4
Kunming 4
Mountain View 4
Nanjing 4
San Mateo 4
Seoul 4
Amsterdam 3
Bắc Giang 3
Casarile 3
Cleveland 3
Columbus 3
Elk Grove Village 3
Irecê 3
Lincoln 3
Manchester 3
Miami 3
Montevideo 3
Palermo 3
Palo Alto 3
Paris 3
Querétaro 3
Redondo Beach 3
Romford 3
San Antonio 3
Suzhou 3
University Park 3
Warsaw 3
Wuhan 3
Allerød Municipality 2
Atlanta 2
Baoding 2
Biên Hòa 2
Totale 4.652
Nome #
Leflunomide-induced DRESS syndrome 529
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 440
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 397
Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapy 333
Image Gallery: Peculiar subungual localization of a second primary melanoma during BRAF inhibitors treatment for metastatic melanoma: case report 274
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities 244
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 216
Cutaneous mastocytosis: a dermatological perspective 208
Efalizumab 187
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature 184
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 178
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 175
Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients 174
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving 153
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 152
Effects of short-term aerobic exercise in a mouse model of Niemann-Pick type C disease on synaptic and muscle plasticity 151
NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas 148
Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab 147
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 140
A case of spontaneous regression of metastatic skin undifferentiated carcinoma 140
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension 131
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 125
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 121
Targeted therapy in nonmelanoma skin cancers 116
TRIM8 and p53: Making the right decision 106
Programmed cell death in the skin 101
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 92
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 85
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients 58
Totale 5.943
Categoria #
all - tutte 19.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022306 17 36 4 23 16 17 19 9 17 41 16 91
2022/2023452 49 47 23 60 45 107 24 28 46 0 16 7
2023/2024179 12 3 15 5 19 67 9 18 0 4 3 24
2024/2025605 43 118 79 49 13 41 48 24 68 36 36 50
2025/20261.190 91 84 140 137 113 52 162 127 125 90 33 36
2026/20274 4 0 0 0 0 0 0 0 0 0 0 0
Totale 5.943